Oncothyreon Inc.
Records under this name other than patents Oncothyreon Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,010,547 | Pharmaceutical compounds Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,973,817 | Pharmaceutical compounds Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,786,524 | Pharmaceutical compounds Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,491,707 | Synthetic lipid-a-analogs and uses thereof Term ended Term ended Nov 15, 2020 · From the USPTO record | Term ended | Term ended Nov 15, 2020 | From the USPTO record |
| US 8,198,400 | Vaccine for modulating between T1 and T2 immune responses Lapsed on the fee record Ended Jun 12, 2020 · From the USPTO record | Lapsed on the fee record | Ended Jun 12, 2020 | From the USPTO record |
| US 8,097,593 | Lipid A and other carbohydrate ligand analogs Lapsed on the fee record Ended Jan 17, 2020 · From the USPTO record | Lapsed on the fee record | Ended Jan 17, 2020 | From the USPTO record |
| US 9,173,929 | Mucinous glycoprotein (MUC-1) vaccine Lapsed on the fee record Ended Nov 3, 2019 · From the USPTO record | Lapsed on the fee record | Ended Nov 3, 2019 | From the USPTO record |
| US 6,544,549 | Multilamellar coalescence vesicles (MLCV) containing biologically active compounds Term ended Term ended Sep 25, 2019 · From the USPTO record | Term ended | Term ended Sep 25, 2019 | From the USPTO record |
| US 9,119,784 | Method of treating patients with a mucinous glycoprotein (MUC-1) vaccine Lapsed on the fee record Ended Sep 1, 2019 · From the USPTO record | Lapsed on the fee record | Ended Sep 1, 2019 | From the USPTO record |
| US 8,889,616 | MUC1 based glycolipopeptide vaccine with adjuvant Lapsed on the fee record Ended Nov 18, 2018 · From the USPTO record | Lapsed on the fee record | Ended Nov 18, 2018 | From the USPTO record |